Experiment: 2M98

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	90% H2O/10% D2O	38	6.0	ambient	310
2	2D 1H-1H NOESY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	90% H2O/10% D2O	38	6.0	ambient	310
3	3D HNCACB	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 13C; U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	100% D2O	38	6.0	ambient	310
4	3D 1H-15N NOESY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 13C; U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	100% D2O	38	6.0	ambient	310
5	2D 1H-1H NOESY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	90% H2O/10% D2O	38	6.0	ambient	310
6	3D 1H-13C NOESY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 13C; U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	100% D2O	38	6.0	ambient	310
7	2D DQF-COSY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	90% H2O/10% D2O	38	6.0	ambient	310
8	2D 1H-1H TOCSY	1.5 mM CALCIUM ION, 36 mM BERYLLIUM TRIFLUORIDE ION, 0.5 mM [U-100% 15N] protein, 1 mM DTT, 0.02 % sodium azide	90% H2O/10% D2O	38	6.0	ambient	310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		Felix

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	500
Conformers Submitted Total Number	26
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	Felix		Accelrys Software Inc.
2	structure solution	X-PLOR		Brunger
3	refinement	X-PLOR		Brunger

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.